Integrated modeling of biomarkers, survival and safety in clinical oncology drug development

Oncology

MIDD

Pharmacometrics

Program strategies and efficiencies

Adv Drug Deliv Rev. 2024 Nov 20:115476. Online ahead of print.

Liu H, Ibrahim EIK, Centanni M, Sarr C, Venkatakrishnan K, Friberg LE.